SCHEMBL9022757

SCHEMBL9022757

CC(C)(C)c1ccc(Cn2cccc2C(=O)O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
CCR9 P51686 10/20 0.49
EPHX2 P34913 4/20 0.48
NR1H4 Q96RI1 3/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1607395 0.82 CNR2 (0.57) HDAC8HDAC6RAB9AEPHX2CA12
SCHEMBL1606703 0.81 CA12 (0.67) RAB9AEPHX2CA12CA1CA2
SCHEMBL8942396 0.81 VEGFA (0.57) NPC1RAB9AEPHX2CA12CA1
SCHEMBL9022567 0.80 CNR2 (0.57) HDAC8HDAC6EPHX2CA12CA1
SCHEMBL24434754 0.80 EPHX2 (0.51) EPHX2CA12CA1CA2CA9
SCHEMBL9022216 0.79 HDAC8 (0.57) HDAC8HDAC6EPHX2CA12CA1
SCHEMBL28689335 0.78 SCN3A (0.49) EPHX2CA12CA1CA2CA9
SCHEMBL24434771 0.77 CNR2 (0.57) RAB9AEPHX2CA12CA1CA2
SCHEMBL24434943 0.76 KDM4E (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL271362 0.76 HDAC8 (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0381141-B1 Novel aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions MERRELL DOW PHARMA (US) 1996-03-20 EP disclosed
US-5041554-A Replace steroids in treatment of inflammatory diseases MERRELL DOW PHARMACEUTICALS INC. (US) 1991-08-20 US disclosed
US-5039695-A Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions MERRELL DOW PHARMACEUTICALS INC. (US) 1991-08-13 US disclosed
EP-0381141-A2 Novel aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions MERRELL PHARMACEUTICALS INC. (US) 1990-08-08 EP disclosed
EP-0381142-A2 Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions MERRELL DOW PHARMACEUTICALS INC. (US) 1990-08-08 EP disclosed